Sergio Siragusa

Palermo, 90127, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.

Journal: International journal of molecular sciences

Published: March 23, 2019

Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

Prolonged anticoagulant treatment in patients with cancer: Where do we stand?

Journal: Thrombosis research

Published: July 26, 2017

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.

Journal: Journal of clinical medicine

Published: January 30, 2017

Reply to e.g. Urrego et Al.

Reply to e.g. Urrego et Al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 15, 2015

Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1).

Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1).

Journal: Thrombosis research

Published: May 29, 2011

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

Journal: American journal of hematology

Published: April 12, 2011

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.

Journal: Annals of hematology

Published: June 05, 2010

How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?

How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?

Journal: British journal of haematology

Published: February 03, 2009

Low molecular weight heparins as antineoplastic agents.

Low molecular weight heparins as antineoplastic agents.

Journal: Recent patents on anti-cancer drug discovery

Published: November 11, 2008

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study.

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study.

Journal: Blood

Published: May 24, 2008

Deferral of assessment of pulmonary embolism.

Deferral of assessment of pulmonary embolism.

Journal: Haematologica

Published: March 07, 2007

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.

The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.

Journal: Thrombosis research

Published: September 30, 2006

Showing 1-12 of 14

Last Updated: 09/26/2026